Diseases, Conditions, Syndromes

Investigational drug can reduce asthma flareups

An investigational drug appears to cut the risk of severe asthma attacks in half for patients who have difficulty controlling the disorder with standard medications, according to results from two multicenter clinical trials.

Medications

No added benefit proven for umeclidinium/vilanterol in COPD

The drug combination umeclidinium/vilanterol (trade name Anoro) has been approved since May 2014 for adults with chronic obstructive pulmonary disease (COPD). In an early benefit assessment pursuant to the Act on the Reform ...

Inflammatory disorders

ERS: Mepolizumab is glucocorticoid-sparing in asthma

(HealthDay)—For patients with eosinophilic asthma, mepolizumab has a glucocorticoid-sparing effect and reduces exacerbations when administered intravenously or subcutaneously, according to two studies published online Sept. ...

Diseases, Conditions, Syndromes

September peak month for kids' asthma flares, study finds

(HealthDay)— Many parents know that allergies are seasonal, but fewer may realize that the same is true of asthma: A new study suggests the riskiest time for children with asthma is September, as they head back to school.

page 7 from 14